Difficulty: Medium
Average Score: 78%
Practice
Children with ALL who carry poor outcome include all the following EXCEPT
Correct answer
C
Rationale
In pediatric oncology, Acute Lymphoblastic Leukemia (ALL) is the most common type of childhood cancer. Understanding the factors that contribute to poor outcomes in children with ALL is crucial for providing effective care.
Option C, hyperdiploidy chromosomal abnormality, is not associated with a poor outcome in children with ALL. In fact, hyperdiploidy is considered a favorable prognostic factor, as it is linked to a better response to treatment and improved survival rates.
On the other hand, options A, B, and D are all factors that can contribute to a poor outcome in children with ALL. Children younger than 1 year or older than 10 years tend to have a less favorable prognosis due to the challenges in treatment and higher risk of complications. T-cell immunophenotype is associated with a poorer response to standard ALL therapy, leading to a higher risk of relapse. An initial leukocyte count of > 50,000 is indicative of high disease burden and is linked to a poorer prognosis.
Educationally, knowing these risk factors helps healthcare providers tailor treatment plans and support strategies for children with ALL. By understanding the impact of different factors on outcomes, healthcare professionals can optimize care and improve the chances of successful treatment for their pediatric patients with ALL.
Option C, hyperdiploidy chromosomal abnormality, is not associated with a poor outcome in children with ALL. In fact, hyperdiploidy is considered a favorable prognostic factor, as it is linked to a better response to treatment and improved survival rates.
On the other hand, options A, B, and D are all factors that can contribute to a poor outcome in children with ALL. Children younger than 1 year or older than 10 years tend to have a less favorable prognosis due to the challenges in treatment and higher risk of complications. T-cell immunophenotype is associated with a poorer response to standard ALL therapy, leading to a higher risk of relapse. An initial leukocyte count of > 50,000 is indicative of high disease burden and is linked to a poorer prognosis.
Educationally, knowing these risk factors helps healthcare providers tailor treatment plans and support strategies for children with ALL. By understanding the impact of different factors on outcomes, healthcare professionals can optimize care and improve the chances of successful treatment for their pediatric patients with ALL.